Abstract:Background: The new complete telomere-to-telomere human genome assembly, T2T-CHM13, and the first draft of the human pangenome reference provide unique opportunities to update the reference genome for epigenetics investigations and clinical research. However, it is largely unclear how these reference genome updates may impact DNA methylation (DNAm) analysis. Results: Compared to the previous GRCh38 assembly, we found an average increase of 7.4% (range 5.4%-9.9% across samples and sequencing methods) in the number of CpGs genome-wide using T2T-CHM13 with data from four commonly used short-read sequencing DNAm profiling methods. The increase in number of CpGs facilitated discovery of 88 new differentially methylated CpGs within cancer driver genes in an epigenome-wide association study (EWAS) of colon cancer. Further, by aligning probe sequences from the commonly used and recently released Illumina DNAm arrays to T2T-CHM13 and GRCh38, we showed the enhanced utility of T2T-CHM13 for evaluation of potential probe cross-reactivity (i.e., where probes match multiple regions) and mismatch (i.e., where probes do not perfectly match the target region), resulting in the identification of new and more reproducible sets of unambiguous probes (i.e., probes uniquely mapping to the target region) (HM450K, n = 430,719; EPIC, n = 777,491; EPICv2, n = 859,216). In EWASs of 24 cancer types, an average of 945 additional differentially methylated CpG sites were identified in the new unambiguous probe set rather than in the GRCh38-based unambiguous probe set, with enrichments in cancer driver genes and cancer signaling pathways. Moreover, the pangenome called 4.5% more CpGs on average in short-read sequencing data than T2T-CHM13 and identified cross-population and population-specific unambiguous probes in DNAm arrays, owing to its improved representation of genetic diversity. These additional CpGs were overlapped with the promoters and gene bodies of various biologically and medically relevant genes and pangenome-based unambiguous probes can potentially facilitate the discovery of DNAm alterations in more than 200 cancer driver genes in each cancer type. Conclusions: Use of T2T-CHM13 and pangenome references can benefit epigenome-wide association studies by including CpGs previously unobserved in short-read sequencing data and by improving the identification of unambiguous probes for DNAm arrays, thus expanding biologically relevant information. This study highlights the practical applications of T2T-CHM13 and pangenome for genome biology and provides a basis for expansion of epigenetics investigations.

Human Pangenome: Far-Reaching Implications in Precision Medicine

The Human Pangenome Project: a global resource to map genomic diversity

The Human Pangenome Reference: the Beginning of a New Era for Genomics.

From the reference human genome to human pangenome: Premise, promise and challenge

A draft human pangenome reference

A Powerful HUPAN on a Pan-Genome Study: Significance and Perspectives

Beyond the Human Genome Project: The Age of Complete Human Genome Sequences and Pangenome References

Semi-automated assembly of high-quality diploid human reference genomes

Proteogenomics analysis of human tissues using pangenomes

HUPAN: a pan-genome analysis pipeline for human genomes

Human pangenome analysis of sequences missing from the reference genome reveals their widespread evolutionary, phenotypic, and functional roles

A Draft Pacific Ancestry Pangenome Reference

The Complete and Fully-Phased Diploid Genome of a Male Han Chinese.

[Chinese Human Genome Project--opportunity and Challenge].

Complete Reference Genome and Pangenome Expand Biologically Relevant Information for Genome-Wide DNA Methylation Analysis Using Short-Read Sequencing and Array Data

Graph pangenome reveals functional, evolutionary, and phenotypic significance of human nonreference sequences

A panoply of pangenomes

Personalized pangenome references

Complex genetic variation in nearly complete human genomes

PPanG: a precision pangenome browser enabling nucleotide-level analysis of genomic variations in individual genomes and their graph-based pangenome

Characterization of Large-Scale Genomic Differences in the First Complete Human Genome